F
Filip K. Knop
Researcher at University of Copenhagen
Publications - 523
Citations - 17834
Filip K. Knop is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Type 2 diabetes & Diabetes mellitus. The author has an hindex of 61, co-authored 437 publications receiving 13614 citations. Previous affiliations of Filip K. Knop include Copenhagen University Hospital & Victor Chang Cardiac Research Institute.
Papers
More filters
Journal ArticleDOI
Vitamin D supplementation improves fasting insulin levels and HDL cholesterol in infertile men.
Rune Holt,Jørgen Holm Pedersen,Elsa Dinsdale,Filip K. Knop,Anders Juul,Niels Jørgensen,Martin Blomberg Jensen +6 more
TL;DR: In this article, the effect of daily vitamin D and calcium supplementation for 150 days on glucose and lipid homeostasis in infertile men was evaluated in a single-center, double-blinded, randomized clinical trial (NCT01304927).
Journal Article
[Effect of incretin hormones GIP and GLP-1 for the pathogenesis of type 2 diabetes mellitus].
Tina Vilsbøll,Filip K. Knop +1 more
TL;DR: The mechanisms of the impaired incretin effect have been found to involve reduced secretion of GLP-1 and a severely impaired effect of GIP and it is currently unknown whether these defects are consequences of the diabetic state or primary pathogenetic factors.
Journal Article
Psoriasis is associated with type 2 diabetes
TL;DR: The current review summarises the evidence in the field and calls for attention on diabetes risk assessment, preventive measures and treatment in patients with psoriasis.
Journal ArticleDOI
The effect of 6-day subcutaneous glucose-dependent insulinotropic polypeptide infusion on time in glycaemic range in patients with type 1 diabetes: a randomised, double-blind, placebo-controlled crossover trial.
Sebastian M. Nguyen Heimbürger,Sebastian M. Nguyen Heimbürger,Bjørn Hoe,Chris N Nielsen,Natasha C. Bergmann,Bolette Hartmann,Jens J. Holst,Tina Vilsbøll,Tina Vilsbøll,Thomas F. Dejgaard,Thomas F. Dejgaard,Mikkel B. Christensen,Filip K. Knop +12 more
TL;DR: In this paper, the effect of exogenous glucose-dependent insulinotropic polypeptide (GIP) during insulin-induced hypoglycaemia in individuals with type 1 diabetes was investigated.
Journal Article
[Glucagon-like peptide 1 receptor agonists for the treatment of Type 2 diabetes].
TL;DR: A review of the efficacy and safety of the GLP-1 receptor agonists for the treatment of Type 2 diabetes finds that of the clinical available compounds only liraglutide, dulag lutide and semaglUTide have demonstrated reductions in the risk of cardiovascular disease.